On 11 August 2026, Brazil’s INPI announced the launch of a collaborative patent examination project with Peru’s INDECOPI, beginning with nine applications. The first batch targets pharmaceuticals, including medicinal chemistry and biopharmaceuticals, biotechnology and natural products. Eligible cases were filed through the PCT route, have corresponding family applications in both Brazil and Peru, and entered the national phase within the project’s specified window. Selected applications move ahead of the ordinary examination queue, and the project does not use a preliminary technical office...
This article updates our report of 17 August, “Brazil and Peru Open Collaborative PCT Review for Life Sciences Patents”.
Brazil’s National Institute of Industrial Property (INPI) and Peru’s INDECOPI have moved patent cooperation into a more operational phase. On 11 August 2026, Brazil’s INPI announced the launch of a collaborative examination project covering an initial group of nine applications in pharmaceuticals, medicinal chemistry and biopharmaceuticals, biotechnology, and natural products. The selected cases must be linked through the PCT route, have corresponding family applications...
Peru's National Institute for the Defence of Competition and the Protection of Intellectual Property (Indecopi) reported on 29 September that its Specialised Chamber for Intellectual Property has confirmed on appeal the first-instance refusal to register copyright in 3 AI-generated images filed by the same applicant, titled 'Viejo Callejón de un solo caño', 'Café del Lunes' and 'Lomo Saltado en Taberna'. The Chamber stated that copyright protects personal and original intellectual creations, so a protected work must result from human creative activity, and...
